Glutamate reduces experimental intestinal hyperpermeability and facilitates glutamine support of gut integrity

World J Gastroenterol. 2011 Mar 28;17(12):1569-73. doi: 10.3748/wjg.v17.i12.1569.

Abstract

Aim: To assess whether glutamate plays a similar role to glutamine in preserving gut wall integrity.

Methods: The effects of glutamine and glutamate on induced hyperpermeability in intestinal cell lines were studied. Paracellular hyperpermeability was induced in Caco2.BBE and HT-29CL.19A cell lines by adding phorbol-12,13-dibutyrate (PDB) apically, after which the effects of glutamine and glutamate on horseradish peroxidase (HRP) diffusion were studied. An inhibitor of glutamate transport (L-trans-pyrrolidine-2,4-dicarboxylic acid: trans-PDC) and an irreversible blocker (acivicin) of the extracellular glutamine to glutamate converting enzyme, γ-glutamyltransferase, were used.

Results: Apical to basolateral HRP flux increased significantly compared to controls not exposed to PDB (n = 30, P < 0.001). Glutamine application reduced hyperpermeability by 19% and 39% in the respective cell lines. Glutamate application reduced hyperpermeability by 30% and 20%, respectively. Incubation of HT29CL.19A cells with acivicin and subsequent PDB and glutamine addition increased permeability levels. Incubation of Caco2.BBE cells with trans-PDC followed by PDB and glutamate addition also resulted in high permeability levels.

Conclusion: Apical glutamate -similar to glutamine- can decrease induced paracellular hyperpermeability. Extracellular conversion of glutamine to glutamate and subsequent uptake of glutamate could be a pivotal step in the mechanism underlying the protective effect of glutamine.

Keywords: Apical; Basolateral; Flux; Glutamate; Glutamine; Gut protection; Gut wall integrity; Intestine; Permeability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Caco-2 Cells
  • Dicarboxylic Acids / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Glutamate Plasma Membrane Transport Proteins / antagonists & inhibitors
  • Glutamate Plasma Membrane Transport Proteins / metabolism
  • Glutamic Acid / metabolism*
  • Glutamine / metabolism*
  • Humans
  • Intestinal Absorption
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism*
  • Isoxazoles / pharmacology
  • Permeability
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Pyrrolidines / pharmacology
  • gamma-Glutamyltransferase / antagonists & inhibitors
  • gamma-Glutamyltransferase / metabolism

Substances

  • Dicarboxylic Acids
  • Enzyme Inhibitors
  • Glutamate Plasma Membrane Transport Proteins
  • Isoxazoles
  • Pyrrolidines
  • Glutamine
  • Phorbol 12,13-Dibutyrate
  • Glutamic Acid
  • pyrrolidine-2,4-dicarboxylic acid
  • gamma-Glutamyltransferase
  • acivicin